|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Multicenter, Open Label, Non-randomized First-in-human Phase 1 Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of BAY 3547926 Alone, and in Combination, in Participants With Advanced Hepatocellular Carcinoma (HCC)
BANTAM-01 NCT06764316  Actif en recrutement
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE HOPITAL FLEURIMONT |
Christine Lawson 819-346-1110 poste 12942 |
Groupe d'étude en oncologie du Québec